191 related articles for article (PubMed ID: 15642814)
21. Vitreous body glutamate concentration in dogs with glaucoma.
Brooks DE; Garcia GA; Dreyer EB; Zurakowski D; Franco-Bourland RE
Am J Vet Res; 1997 Aug; 58(8):864-7. PubMed ID: 9256971
[TBL] [Abstract][Full Text] [Related]
22. Regional optic nerve damage in experimental mouse glaucoma.
Mabuchi F; Aihara M; Mackey MR; Lindsey JD; Weinreb RN
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4352-8. PubMed ID: 15557443
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, I: Functional measures.
Hare WA; WoldeMussie E; Lai RK; Ton H; Ruiz G; Chun T; Wheeler L
Invest Ophthalmol Vis Sci; 2004 Aug; 45(8):2625-39. PubMed ID: 15277486
[TBL] [Abstract][Full Text] [Related]
24. Axoplasmic flow during chronic experimental glaucoma. 1. Light and electron microscopic studies of the monkey optic nervehead during development of glaucomatous cupping.
Gaasterland D; Tanishima T; Kuwabara T
Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):838-46. PubMed ID: 81192
[TBL] [Abstract][Full Text] [Related]
25. Correlation between retinal ganglion cell death and chronically developing inherited glaucoma in a new rat mutant.
Thanos S; Naskar R
Exp Eye Res; 2004 Jul; 79(1):119-29. PubMed ID: 15183107
[TBL] [Abstract][Full Text] [Related]
26. Histomorphometric analysis of optic nerve changes in experimental glaucoma.
Yücel YH; Kalichman MW; Mizisin AP; Powell HC; Weinreb RN
J Glaucoma; 1999 Feb; 8(1):38-45. PubMed ID: 10084273
[TBL] [Abstract][Full Text] [Related]
27. Analysis of a method for establishing a model with more stable chronic glaucoma in rhesus monkeys.
Yan Z; Tian Z; Chen H; Deng S; Lin J; Liao H; Yang X; Ge J; Zhuo Y
Exp Eye Res; 2015 Feb; 131():56-62. PubMed ID: 25536534
[TBL] [Abstract][Full Text] [Related]
28. Intravitreal injections of GDNF-loaded biodegradable microspheres are neuroprotective in a rat model of glaucoma.
Jiang C; Moore MJ; Zhang X; Klassen H; Langer R; Young M
Mol Vis; 2007 Sep; 13():1783-92. PubMed ID: 17960131
[TBL] [Abstract][Full Text] [Related]
29. Neuroprotection by sodium channel blockade with phenytoin in an experimental model of glaucoma.
Hains BC; Waxman SG
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4164-9. PubMed ID: 16249495
[TBL] [Abstract][Full Text] [Related]
30. Immune priming and experimental glaucoma: the effect of prior systemic lipopolysaccharide challenge on tissue outcomes after optic nerve injury.
Narayan DS; Casson RJ; Ebneter A; Chidlow G; Grace PM; Hutchinson MR; Wood JP
Clin Exp Ophthalmol; 2014 Aug; 42(6):539-54. PubMed ID: 24373007
[TBL] [Abstract][Full Text] [Related]
31. Correlation of pseudoexfoliative material and optic nerve damage in pseudoexfoliation syndrome.
Gottanka J; Flügel-Koch C; Martus P; Johnson DH; Lütjen-Drecoll E
Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2435-46. PubMed ID: 9375560
[TBL] [Abstract][Full Text] [Related]
32. Comparison of ganglion cell loss and cone loss in experimental glaucoma.
Wygnanski T; Desatnik H; Quigley HA; Glovinsky Y
Am J Ophthalmol; 1995 Aug; 120(2):184-9. PubMed ID: 7639302
[TBL] [Abstract][Full Text] [Related]
33. Changes in reversal of cupping in experimental glaucoma. Longitudinal study.
Shirakashi M; Nanba K; Iwata K
Ophthalmology; 1992 Jul; 99(7):1104-10. PubMed ID: 1495790
[TBL] [Abstract][Full Text] [Related]
34. Increase in dephosphorylation of the heavy neurofilament subunit in the monkey chronic glaucoma model.
Kashiwagi K; Ou B; Nakamura S; Tanaka Y; Suzuki M; Tsukahara S
Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):154-9. PubMed ID: 12506068
[TBL] [Abstract][Full Text] [Related]
35. Laser-induced primate glaucoma. II. Histopathology.
Radius RL; Pederson JE
Arch Ophthalmol; 1984 Nov; 102(11):1693-8. PubMed ID: 6541903
[TBL] [Abstract][Full Text] [Related]
36. [Optic disc measurements with computerized image analysis in experimental chronic glaucoma].
Shirakashi M; Nanba K; Iwata K; Fukuchi T; Hara H
Nippon Ganka Gakkai Zasshi; 1989 Aug; 93(8):852-8. PubMed ID: 2610166
[TBL] [Abstract][Full Text] [Related]
37. Surgical lowering of elevated intraocular pressure in monkeys prevents progression of glaucomatous disease.
Nickells RW; Schlamp CL; Li Y; Kaufman PL; Heatley G; Peterson JC; Faha B; Ver Hoeve JN
Exp Eye Res; 2007 Apr; 84(4):729-36. PubMed ID: 17291496
[TBL] [Abstract][Full Text] [Related]
38. Viscoelastic material properties of the peripapillary sclera in normal and early-glaucoma monkey eyes.
Downs JC; Suh JK; Thomas KA; Bellezza AJ; Hart RT; Burgoyne CF
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):540-6. PubMed ID: 15671280
[TBL] [Abstract][Full Text] [Related]
39. Retinal proteomic changes following unilateral optic nerve transection and early experimental glaucoma in non-human primate eyes.
Stowell C; Arbogast B; Cioffi G; Burgoyne C; Zhou A
Exp Eye Res; 2011 Jul; 93(1):13-28. PubMed ID: 21530506
[TBL] [Abstract][Full Text] [Related]
40. Configuration of the drainage angle, intraocular pressure, and optic disc cupping in subjects with chronic angle-closure glaucoma.
Aung T; Lim MC; Chan YH; Rojanapongpun P; Chew PT;
Ophthalmology; 2005 Jan; 112(1):28-32. PubMed ID: 15629816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
